Sinusitis Treatment Assoc New York City, NY - 10065

Sinusitis Treatment Assoc is categorized under Physicians Offices in New York City, NY and active since 1980.

Sinusitis Treatment Assoc was established in 1980, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Wellington S Tichenor at the company’s single location by writing to 642 Park Avenue, New York City, New York NY 10065 or by phoning (212) 517-0006. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sinusitis Treatment Assoc
Contact Person: Wellington S Tichenor
Address: 642 Park Avenue, New York City, New York 10065
Phone Number: (212) 517-0006
Website Address: sinuses.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1980
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Sinusitis Treatment Assoc was started in 1980 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Wellington S Tichenor for inquiries that concern Sinusitis Treatment Assoc by calling the company number (212) 517-0006, as your correspondence is most welcome. Additionally, the physical location of the single location of Sinusitis Treatment Assoc can be found at the coordinates 40.76767,-73.96653 as well as the street address 642 Park Avenue in New York City, New York 10065.

For its online presence, you may visit Sinusitis Treatment Assoc’s website at sinuses.com and engage with its social media outlets through on Twitter and on Facebook.